How to Leverage eCOA for Improved Signal Detection in Pediatric & Rare Disorder Trials

March 4, 2019


Combining eSource Technology with Expert Clinical Science to Reduce Rater Errors on Cognitive, Behavioral and Developmental Assessments for Infants to Young Adults

High-quality data are critical when seeking to measure treatment outcomes, but this is especially true —and especially challenging—in rare disease trials where the stakes are high, the assessments are complex and the eligible participants are so few and far between. Missing data and non-standard data collection present considerable threats to data integrity, and when the trial sites are numerous and geographically dispersed, inter-rater variability can further compromise data quality. Electronic clinical outcome assessment (eCOA), particularly when optimized with expert clinical science input, is a proven approach to reduce missing data and enable correct and consistent assessments for a more accurate picture of treatment benefit.

In this webinar, Dr. Pamela Ventola and Mr. Jonathan Andrus will share their collective four decades of experience in developmental disabilities, pediatric neuropsychology, eClinical systems, data management and regulatory compliance to outline how clinical trial sponsors are incorporating leading-edge data capture and monitoring strategies to optimize clinical outcome assessments.

Featured Speakers

  • Pamela Ventola, Senior Science Director, Pediatrics and Rare Disease, Cogstate
  • Jonathan Andrus, Chief Business Officer, Clinical Ink

Access Recording

Back to Webinars